Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges

New antiviral therapies cure most patients with hepatitis C and prevent the development of cirrhosis and hepatocellular carcinoma. The major challenges for global hepatitis C virus eradication are the identification of patients with chronic hepatitis C, referrals to treatment, and elevated drug prices. See also pages 000-000.

http://ift.tt/2EWwnNj